Arteriovenous Malformations in Children: A Pediatric Neurosurgeons Perspective
-
June 19, 2026
June 19, 2026
A nationally representative US cohort identified a contrast sensitivity threshold associated with self-reported visual disability.
July 7, 2026
The first controlled phase 3 trial of a genetic therapy for Dravet syndrome is now underway – with Phoenix Children's as one of 28 sites nationwide.